Medical College of Georgia
 School of Medicine  |  Neurology A-Z Index  |  MCG Home  |  Site Search 

  Neurology> Research Programs / Clinical Trials>

Stroke Research in Sickle Cell Disease
   
  Neurology Research Programs / Clinical Trials
 
  Statement of Purpose
 
  Stem Cell Info/Definitions
 
  Faculty and Staff
 
  Current Projects
 
  Publications
 
  FAQ
 
  Stem Cell Links
 
 
 

Frequently Asked Questions

When will you treat humans?
We are currently conducting experiments to see if the treatment works in animal models for human disease. Our results are promising. Before the treatment can be used in humans, however, we will need to show that the treatment is safe and that the cells can be prepared under safe conditions for administration to humans. The preparation will have to be approved by the FDA. This will require at least two years.

Why is there an ethical controversy about the use of stem cells?
Often the distinction is not made clear between adult and embryonic stem cells. Adult stem cells are obtained from living donors. Embryonic stem cells are obtained from fetuses or from embryos made in the laboratory. We use adult stem cells in our work.

Why not just ahead and give the cells to people?
Stem cell therapy should be thought of as a potentially powerful drug. We must consider the safety of the therapy.

I hear about people getting stem cells. What’s going on?
Bone marrow stem cells have been used in cancer treatment for some time. This is almost a routine use. Others may receive stem cell treatment from unregulated sources, such as those outside the US. The latter is potentially dangerous.


For more information on Stem Cell Research, please email:
MCGNEUROLOGYSTEMCELLS@mail.mcg.edu

   
  © 2003 MCG

Questions and Comments to Bill Hamilton 


  May 11, 2005


School of Medicine  |  Medical College of Georgia